Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study132

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study47

Views

Views
November 202511
December 20256
January 202610
February 20260
March 20267
April 202613
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil8
Finland5
Spain4
Argentina3
France2
Morocco2
South Africa2
Ecuador2
Canada1
 

Top cities views

Views
San Jose5
Helsinki5
Madrid4
Ayacucho1
Bogotá1
Capivari1
Caseros1
Caxias1
Fortaleza1
Frankfurt am Main1